SNOA

Sonoma Pharmaceuticals Inc

1.24

Nov 11 • 3:59 PM ET +0.10 (8.77%)

1.24

Aftermarket • 5:13 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic USA Nano NASD

Nov 10, 4:21 PMSonoma Pharmaceuticals reports Q2 2027 results with non-GAAP EPS -$0.33, revenue $5.6M and first-ever pre-tax net income $382,000

Peers: BFRI SMTI NXGL CUPR ORGO YCBD DERM SNWV MDXG RCEL

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	5.94M
Enterprise Value	1.93M
Income	-1.80M
Sales	23.49M
Book/sh	1.31
Cash/sh	0.96
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	259
IPO	Jan 25, 2007

P/E	-
Forward P/E	-
PEG	-
P/S	0.25
P/B	0.95
P/C	1.29
P/FCF	-
EV/EBITDA	-
EV/Sales	0.08
Quick Ratio	2.68
Current Ratio	3.48
Debt/Eq	0.09
LT Debt/Eq	0.06
Option/Short	No / Yes

EPS (ttm)	-0.91
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	60.40% 47.50%
Sales past 3/5Y	13.74% 0.95%
EPS Y/Y TTM	58.68%
Sales Y/Y TTM	38.69%
EPS Q/Q	95.87%
Sales Q/Q	28.02%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	- -

Insider Own	0.44%
Insider Trans	0.00%
Inst Own	2.82%
Inst Trans	1.06%
ROA	-11.60%
ROE	-34.54%
ROIC	-25.67%
Gross Margin	39.23%
Oper. Margin	-3.32%
Profit Margin	-7.65%
SMA20	9.30%
SMA50	2.61%
SMA200	-23.23%
Trades

Shs Outstand	5.06M
Shs Float	4.77M
Short Float	1.40%
Short Ratio	1.15
Short Interest	0.07M
52W High	3.95 -68.61%
52W Low	0.85 45.87%
Volatility	7.73% 6.61%
ATR (14)	0.08
RSI (14)	59.13
Beta	1.30
Rel Volume	5.60
Avg Volume	57.91K
Volume	324,222

Perf Week	11.71%
Perf Month	5.08%
Perf Quarter	-7.46%
Perf Half Y	7.83%
Perf YTD	-65.93%
Perf Year	-66.80%
Perf 3Y	-55.90%
Perf 5Y	-98.91%
Perf 10Y	-99.85%
Recom	1.00
Target Price	12.00
Prev Close	1.14
Price	1.24
Change %	8.77%

Nov-10-26 04:10PM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax (ACCESSWIRE) +8.77%
Aug-06-26 09:00AM	Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA (ACCESSWIRE) +10.62%
Jun-30-26 09:00AM	Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution (ACCESSWIRE)
Jun-16-26 04:15PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results (ACCESSWIRE)
Apr-24-26 09:21AM	Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering (ACCESSWIRE) -36.67%
08:30AM	Loading…
Mar-24-26 08:30AM	Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart (ACCESSWIRE) -8.24%
Mar-18-26 08:30AM	Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin (ACCESSWIRE)
Feb-10-26 04:10PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results (ACCESSWIRE)
Jan-28-26 04:15PM	Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development (ACCESSWIRE)
Nov-13-25 08:30AM	National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Nov-06-25 04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Dusseldorf (ACCESSWIRE)
Nov-04-25 08:56AM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results (ACCESSWIRE)
Oct-14-25 08:30AM	Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals (ACCESSWIRE)
Oct-07-25 08:30AM	Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA (ACCESSWIRE)
Sep-25-25 04:01PM	Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 (ACCESSWIRE)
08:30AM	Loading…
Aug-26-25 08:30AM	National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Aug-19-25 08:50AM	Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock (Zacks)
Aug-14-25 01:55PM	Sonoma Pharmaceuticals Soars 95% After Walmart, Amazon Retail Debut (GuruFocus.com) +72.67%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-13-25 04:01PM	Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains (ACCESSWIRE)
Aug-07-25 04:15PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results (ACCESSWIRE)
Jul-14-25 08:50AM	Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-10-25 04:00AM	The early winner in the 'Dexit' war for corporate relocations: Nevada (Yahoo Finance) +23.12%
Jun-17-25 04:10PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results (ACCESSWIRE)
May-20-25 10:35AM	Tesla's Texas Plan B if Delaware wont reinstate Elon Musk's pay. It's not about the money, says Elon. (Yahoo Finance)
09:34AM	The Texas Plan B if Delaware wont reinstate Elon Musk's Tesla pay haul (Yahoo Finance)
Apr-22-25 04:01PM	Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain (ACCESSWIRE) +69.53%
Mar-27-25 08:50AM	Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain (Zacks) -8.28%
Mar-26-25 12:44PM	Delaware passes law designed to stop more Elon Musks from leaving state (Yahoo Finance)
Mar-11-25 08:50AM	Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors (Zacks) +21.86%
04:01PM	Loading…
Mar-10-25 04:01PM	Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) (ACCESSWIRE) +40.20%
Feb-25-25 04:01PM	Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando (ACCESS Newswire)
Feb-05-25 04:05PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
Dec-05-24 08:30AM	Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices (ACCESSWIRE)
Nov-27-24 08:50AM	Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock (Zacks)
Nov-21-24 04:06PM	Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States (ACCESSWIRE)
Nov-11-24 04:20PM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel (ACCESSWIRE) +10.71% -13.23%
Nov-07-24 08:45AM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
Oct-31-24 04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Dusseldorf (ACCESSWIRE) -7.59%
04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf (ACCESS Newswire)
Oct-22-24 08:35AM	Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada (ACCESSWIRE)
Oct-21-24 04:01PM	Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences (ACCESSWIRE) -6.01%
Sep-19-24 08:30AM	Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE) -10.93%
Sep-17-24 08:30AM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution (ACCESSWIRE) +23.52%
Sep-11-24 08:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line (ACCESSWIRE)
Aug-28-24 06:10AM	Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock (ACCESSWIRE) -24.99%
Aug-26-24 08:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff (ACCESSWIRE)
Aug-21-24 08:45AM	Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States (ACCESSWIRE) -8.45%
Aug-12-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -9.48%
Aug-08-24 04:10PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results (ACCESSWIRE) +13.49% -19.70%
Jul-15-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-12-24 07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-09-24 07:30AM	Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine (ACCESSWIRE) -7.27%
Jun-28-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jun-18-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +13.95%
Jun-17-24 09:52PM	SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024 (InvestorPlace) -5.76%
05:00PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results (ACCESSWIRE)
May-30-24 07:47AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -21.15%
May-09-24 07:30AM	Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores (ACCESSWIRE)
Apr-09-24 07:30AM	Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States (ACCESSWIRE) +6.33%
Apr-04-24 07:30AM	Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections (ACCESSWIRE)
Mar-28-24 04:01PM	Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences (ACCESSWIRE) -7.88%
Mar-27-24 07:30AM	Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals (ACCESSWIRE)
Feb-08-24 04:10PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Jan-23-24 07:30AM	Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use (ACCESSWIRE)
Jan-09-24 09:15AM	NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonomas Extensive Distributor Network (Business Wire)
Nov-13-23 04:10PM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results (ACCESSWIRE) +11.38%
Nov-03-23 07:30AM	Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference (ACCESSWIRE) +8.40%
Oct-26-23 09:10AM	Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock (ACCESSWIRE) -49.83%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-15-23 07:30AM	National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Aug-10-23 04:15PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Aug-03-23 07:30AM	Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board (ACCESSWIRE)
Jun-22-23 07:30AM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results (ACCESSWIRE)
Jun-09-23 04:40PM	Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product (Investopedia) +44.33% -11.43%
Jun-08-23 04:01PM	Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union (ACCESSWIRE) +5.40%
Apr-19-23 01:30PM	Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price (Simply Wall St.)
Apr-11-23 07:30AM	Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care (ACCESSWIRE)
Mar-28-23 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia (ACCESSWIRE) +15.03% -18.03%
Mar-02-23 07:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant (ACCESSWIRE)
Feb-14-23 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results (ACCESSWIRE)
Jan-31-23 07:30AM	Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea (ACCESSWIRE)
Jan-25-23 07:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products (ACCESSWIRE) +40.83%
Jan-04-23 07:30AM	Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas (ACCESSWIRE) -6.30%
Nov-17-22 05:33AM	Sonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022) (Simply Wall St.)
Nov-14-22 04:15PM	Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results (ACCESSWIRE) +7.21%
Oct-27-22 04:01PM	Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States (ACCESSWIRE)
Oct-06-22 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany (ACCESSWIRE) -8.81%
Aug-11-22 04:30PM	Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results (ACCESSWIRE)
Aug-02-22 04:30PM	Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply (ACCESSWIRE) +7.96%
Jul-13-22 04:45PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results (ACCESSWIRE)
Jun-01-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19 (Business Wire) -11.59%
May-03-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S. (Business Wire) +31.55%
Mar-30-22 11:20AM	Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa (Benzinga) +13.39%
06:00AM	Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa (Business Wire)
Feb-11-22 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results (Business Wire) -6.90%
Jan-28-22 09:38AM	HBC Financial Services, PLLC Buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, ... (GuruFocus.com)
Jan-20-22 04:40PM	Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China (Business Wire) -10.35%
Jan-05-22 04:55PM	Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022 (Business Wire)
Nov-15-21 08:00AM	Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results (Business Wire)

Show Previous News

Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

J.D.Ms. Amy M. Trombly Esq.

Chief Financial OfficerMr. Jerome J. Dvonch CPA

Senior Vice President of RegulatoryMr. Arturo Angel

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

SNOA

Sonoma Pharmaceuticals Inc

Upgrade your Finviz experience

All the Features.
Half the Price.